Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Preventive MedicineReferences
- SUPRE information leaflet.WHO, Geneva2002
- Leading causes of unintentional and intentional injury mortality: U.S., 2000–2009.Am J Public Health. 2012; 102: e84-e92
- Trends in suicide rates among persons ages 10 years and older, by sex, U.S., 1991–2009.CDC, Atlanta GA2014
- Psychological autopsy studies of suicide: a systematic review.Psychol Med. 2003; 33: 395-405
- Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries.Int J Soc Psychiatry. 2013; 59: 545-554
- Toward a clinical model of suicidal behavior in psychiatric patients.Am J Psychiatry. 1999; 156: 181-189
- Suicide prevention interventions and referral/follow-up services: a systematic review.Department of Veterans Affairs, Health Services Research and Development Service, Washington DC2012 (VA-ESP Project #05-225. www.hsrd.research.va.gov/publications/esp/suicide-interventions.pdf)
O’Connor E, Gaynes B, Burda BU, et al. Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force. ncbi.nlm.nih.gov/books/NBK137737/.
NICE. Self-harm: the NICE guideline on longer-term management. nccmh.org.uk/guidelines_selfharm_ltm.html.
- Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?.Am J Psychiatry. 2002; 159: 469-473
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.Lancet. 2004; 363: 1341-1345
- Diagnostic and statistical manual of mental disorders.5th ed. APA, Washington DC2013
- Best practice elements of multilevel suicide prevention strategies.Crisis. 2011; 32: 319-333
- Psychiatrists’ attitude towards and knowledge of clozapine treatment.J Psychopharmacol. 2010; 24: 965-971
Pharmacy Times. Top 200 drugs of 2011. Plainsboro NJ: Pharmacy Times, 2012. www.pharmacytimes.com/_media/_pdf/Top_200_Drugs_2011_Total_Rx.pdf.
- Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Arch Gen Psychiatry. 2003; 60: 82-91
- Reducing suicide risk in schizophrenia: focus on the role of clozapine.CNS Drugs. 2000; 14: 355-365
- Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?.Pharmacol Biochem Behav. 2006; 84: 598-608
- Intracellular modulation of NMDA receptor function by antipsychotic drugs.J Neurosci. 2000; 20: 4011-4020
- Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain.Psychopharmacology. 2012; 222: 663-674
- Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.J Affect Disord. 2009; 117: S26-S43
- Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression.Neuropsychopharmacology. 2012; 37: 697-706
- Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.Am J Psychiatry. 2011; 168: 1050-1056
- Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels.J Psychiatr Res. 2011; 45: 1489-1496
- Treatment emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.Depress Anxiety. 2011; 28: 303-309
- Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial.Acta Psychiatr Scand. 2008; 118: 469-479
- Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.J Clin Psychiatry. 2008; 69: 1228
- Suicide prevention by lithium SUPLI—challenges of a multi-center prospective study.Arch Suicide Res. 2005; 9: 27-34
- Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression.Am J Psychiatry. 1998; 155: 543-547
- Neurobiological aspects of suicide and suicide attempts in bipolar disorder.Transl Neurosci. 2013; (In press)
- Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.Am J Psychiatry. 2005; 162: 1805-1819
- Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis.BMJ. 2013; 346: f3646
- Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.Bipolar Disorders. 2006; 8: 625-639
- The suicide-preventive and mortality reducing effect of lithium.Lithium in neuropsychiatry: the comprehensive guide. Informa Healthcare, Oxfordshire2006
- Lithium treatment reduces suicide risk in recurrent major depressive disorder.J Clin Psychiatry. 2007; 68: 380-383
- Arguments for the specificity of the antisuicidal effect of lithium.Eur Arch Psychiatry Clin Neurosci. 2001; 251: S1172-S1175
- Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995–2005.Acta Psychiatrica Scandinavica. 2009; 120: 37-44
- Epidemiological data suggest antidepressants reduce suicide risk among depressives.J Affect Disorders. 1996; 41: 1-8
- Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.J Clin Psychiatry. 2011; 72: 548-555
- Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.Clin Ther. 2006; 28: 1912-1921
- The role of psychopharmacology in suicide prevention.Epidemiol Psychiatr Soc. 2009; 18: 172-178
- Bipolar pharmacotherapy and suicidal behavior: part 3: impact of antipsychotics.J Affect Disorders. 2007; 103: 23-28
- Transcranial direct current stimulation in severe, drug-resistant major depression.J Affect Disord. 2009; 118: 215-219
- A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression.Arch Gen Psychiatry. 2006; 63: 856-864
- Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.Biol Psychiatry. 2012; 71: 939-946
- Antidepressant effects of ketamine in depressed patients.Biol Psychiatry. 2000; 47: 351-354
- Synaptic mechanisms underlying rapid antidepressant action of ketamine..Am J Psychiatry. 2012; 169: 1150-1156
- GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.Neuropsychopharmacology. 2013; 38: 729-742
- A randomized trial of a low-trapping nonselective N-methyl-d-aspartate channel blocker in major depression.Biol Psychiatry. 2012; S0006-3223: 941-949
- Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder.J Clin Psychiatry. 2010; 71: 1605-1611
- Connecting inflammation with glutamate agonism in suicidality.Neuropsychopharmacology. 2013; 38: 743-752
- A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.Int J Neuropsychopharmacol. 2011; 14: 1127-1131
- Standardization, integration, and sharing-leveraging research investments.Biol Psychiatry. 2011; 70: 5-6
- A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders.Psychol Med. 2013; 44: 1663-1673
- Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication.Mol Psychiatr. 2009; 15: 868-876
- 5-HIAA, cortisol and DHEAS levels in suicide attempters.Eur Neuropsychopharmacol. 2013; 23: 1280-1287